T2 Biosystems, Inc. (NASDAQ:TTOO) Q2 2023 Earnings Call Transcript
Operator: Greetings. Welcome to T2 Biosystems, Inc. Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Stay updated with breaking news from John Sperzel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Greetings. Welcome to T2 Biosystems, Inc. Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Received FDA Breakthrough Device Designation for Candida auris test, achieved record quarterly sepsis test panel orders and received second largest sepsis driven T2Dx® Instrument order LEXINGTON,...
T2 Biosystems Inc (NASDAQ: TTOO) shares are trading higher Thursday after the FDA granted Breakthrough Device designation for the company's Candida auris
12.07.2023 - Received record quarterly sepsis test panel orders and strengthened balance sheetLEXINGTON, Mass., July 12, 2023 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic ... Seite 1
Operator: Greetings. Welcome to the T2 Biosystems, Inc. First Quarter 2023 Earnings Conference Call. [Operator Instructions]. I will now turn the conference over to your host, Trip Taylor.